UNBELIEVABLE: Health cancer | History Defined

World’s first mRNA cancer jab for melanoma cuts risk of death by 42%

The study included more than 1,100 people with high-risk melanoma that had been surgically removed.

Evening Standard · Oct 23

One Yellow Eye in a 28-Year-Old with Lung Cancer Was a Tumor Inside the Eye, Not Jaundice

A 28-year-old with lung cancer had one yellow eye but normal liver tests. Scans showed his cancer had spread to the back of that eye.

Medical Daily · Oct 23

Jemperli Wins Accelerated FDA Approval for a Rectal Cancer Subtype as Most Trial Patients Avoided Surgery

FDA gave Jemperli accelerated approval for dMMR rectal cancer. Most trial patients skipped surgery, but the data are interim. What patients should ask.

Medical Daily · Oct 20

BioNTech mRNA Therapy Plus Keytruda Missed Its Tumor Progression Goal in HPV-Linked Head and Neck Cancer

BioNTech's BNT113 with Keytruda did not slow HPV16-positive head and neck cancer in a Phase 2/3 first analysis. Survival data are still pending.

Medical Daily · Oct 14

Famous Panty Liner Brand Faces Lawsuit As Hundreds of Women Allege Harm From Cancer-Causing Chemical

Hundreds of women have sued Carefree panty liner manufacturers, alleging the products contained PFOA and caused serious illnesses. The companies deny no liability has been established.

International Business Times UK · Oct 14

Pope Leo cancer diagnosis: What is lung adenocarcinoma, symptoms, treatments & who are at risk

Pope Leo has been found to have lung adenocarcinoma, which is among the most common types of lung cancer. He recently had surgery to excise the lower lobe of his right lung. This cancer is frequently asymptomatic in the beginning stages, and known risk factors include both smoking and certain…

The Economic Times · Oct 14

What we know about Pope Leo XIV's lung cancer diagnosis

Pope Leo underwent surgery on Tuesday to remove a cancerous tumour from his right lung after saying that a nodule had been "detected at a very early stage". Following a "successful" operation, the Vatican said the 71-year-old pontiff would undergo additional testing.

France 24 · Oct 14

Tecentriq Plus Chemotherapy Wins Approval for Stage III dMMR Colon Cancer After Halving Recurrence or Death Risk

The FDA approved Tecentriq plus chemotherapy after surgery for stage III dMMR colon cancer after a trial halved the risk of recurrence or death.

Medical Daily · Oct 11

AbbVie's Experimental Cancer Drug Temab-A Earns Two FDA Breakthrough Designations for Advanced Colorectal and Lung Cancers

FDA gave AbbVie's Temab-A two breakthrough designations for advanced colorectal and lung cancers. What the status means and what patients should know.

Medical Daily · Oct 10

Adding Epcoritamab to R-CHOP Cut Lymphoma Progression or Death Risk by 51% in Topline Phase 3 Trial Results

Topline phase 3 data show epcoritamab plus R-CHOP cut progression or death risk by 51% in newly diagnosed DLBCL. Results are not yet peer-reviewed.

Medical Daily · Oct 8